Aterian, Inc. (NASDAQ:ATER – Get Free Report) was the recipient of a significant growth in short interest in the month of January. As of January 30th, there was short interest totaling 291,202 shares, a growth of 96.5% from the January 15th total of 148,224 shares. Based on an average daily trading volume, of 113,257 shares, the days-to-cover ratio is presently 2.6 days. Currently, 3.6% of the company’s shares are short sold. Currently, 3.6% of the company’s shares are short sold. Based on an average daily trading volume, of 113,257 shares, the days-to-cover ratio is presently 2.6 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aterian in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $4.00.
Read Our Latest Analysis on Aterian
Aterian Stock Down 6.2%
Aterian (NASDAQ:ATER – Get Free Report) last announced its earnings results on Thursday, November 13th. The company reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.63) by $0.35. Aterian had a negative net margin of 15.73% and a negative return on equity of 47.45%. The business had revenue of $19.02 million during the quarter, compared to the consensus estimate of $19.88 million.
Institutional Trading of Aterian
Several large investors have recently modified their holdings of the business. Citadel Advisors LLC lifted its stake in shares of Aterian by 222.0% in the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares in the last quarter. Susquehanna International Group LLP increased its holdings in Aterian by 310.2% during the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Aterian by 73.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock valued at $45,000 after purchasing an additional 9,026 shares in the last quarter. XTX Topco Ltd acquired a new position in shares of Aterian in the 2nd quarter valued at approximately $55,000. Finally, Ground Swell Capital LLC purchased a new position in shares of Aterian during the 2nd quarter valued at approximately $58,000. 7.02% of the stock is currently owned by institutional investors and hedge funds.
Aterian Company Profile
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
Recommended Stories
- Five stocks we like better than Aterian
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
